A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin.
Saved in:
| Title: | A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin. |
|---|---|
| Authors: | Olatoke O; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Zah V; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Stanicic F; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Vukicevic D; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Yfantopoulos P; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Thompson C; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA., DeGeorge MK; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA., Passik S; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA. |
| Source: | ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2022 Mar 03; Vol. 14, pp. 119-128. Date of Electronic Publication: 2022 Mar 03 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101560564 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6981 (Print) Linking ISSN: 11786981 NLM ISO Abbreviation: Clinicoecon Outcomes Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
